Heron Therapeutics announces FDA approval of Zynrelef for the management of postoperative pain for up to 72 hours
Heron Therapeutics, Inc. announced that the FDA has approved Zynrelef (bupivacaine and meloxicam) extended-release solution for use in adults for soft tissue or periarticular instillation to produce postsurgical… read more.